Glutamine in the intensive care unit

Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):98-104. doi: 10.1097/MCO.0000000000000014.

Abstract

Purpose of review: To analyze the recent literature (2011-2013) on glutamine supplementation of parenteral and enteral nutrition in critically ill patients. Potential confounding factors that may explain conflicting results are suggested.

Recent findings: Some recent, prospective, multicenter trials and two small trials yielded conflicting results that weigh heavily in the conclusions of a recent meta-analysis. Heterogeneity of the patients enrolled (especially in terms of injury severity, age, and basal nutritional status) and difficulties in identifying patients truly in need of glutamine supplementation may explain the discrepancies.

Summary: Glutamine supplementation has been recognized as beneficial in acutely injured patients. However, recent conflicting results in either 'real-life conditions' or very severe situations suggest that its indications need to be more precisely determined.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Critical Illness / therapy
  • Dietary Supplements
  • Enteral Nutrition
  • Evidence-Based Medicine
  • Glutamine / administration & dosage
  • Glutamine / blood*
  • Humans
  • Intensive Care Units*
  • Liver Failure / drug therapy
  • Liver Failure / pathology
  • Meta-Analysis as Topic
  • Parenteral Nutrition
  • Randomized Controlled Trials as Topic
  • Renal Insufficiency / drug therapy
  • Renal Insufficiency / pathology

Substances

  • Glutamine